Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.33 |
| ▸ | FDPS | P14324 | 3/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.32 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ADH1B | P00325 | 1/20 | 0.32 |
| ▸ | ADH1C | P00326 | 1/20 | 0.32 |
| ▸ | ADH1A | P07327 | 1/20 | 0.32 |
| ▸ | ADH4 | P08319 | 1/20 | 0.32 |
| ▸ | ADH7 | P40394 | 1/20 | 0.32 |
| ▸ | LAP3 | P28838 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5575845 | 1.00 | MAPT (0.36) | MAPTACE2GPR84FDPSFFAR1 | |
| SCHEMBL5573070 | 1.00 | MAPT (0.36) | MAPTACE2GPR84FDPSFFAR1 | |
| SCHEMBL5572973 | 1.00 | MAPT (0.36) | MAPTACE2GPR84FDPSFFAR1 | |
| SCHEMBL5575330 | 0.87 | MAPT (0.35) | MAPTACE2GPR84FDPSFFAR1 | |
| SCHEMBL5575209 | 0.87 | MAPT (0.35) | MAPTACE2GPR84FDPSFFAR1 | |
| SCHEMBL5575596 | 0.87 | MAPT (0.35) | MAPTACE2GPR84FDPSFFAR1 | |
| SCHEMBL5575270 | 0.79 | ZDHHC7 (0.35) | MAPTACE2GPR84FDPSFFAR1 | |
| SCHEMBL5574686 | 0.77 | MAPT (0.33) | MAPTACE2GPR84FDPSFFAR1 | |
| SCHEMBL395349 | 0.76 | ZDHHC7 (0.33) | MAPTACE2 | |
| SCHEMBL1364340 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1817425-B1 | TRICHLORO SILYL ALKYL ISOCYANATE MOLECULE AND SURFACE MODIFIED MINERAL SUBSTRATE | CENTRE NAT RECH SCIENT (FR) | 2013-03-06 | — | — | EP | disclosed |
| US-8067338-B2 | Trichloro silyl alkyl isocyanate molecule and surface modified mineral substrate | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2011-11-29 | — | — | US | disclosed |
| US-20090023590-A1 | Trichloro Silyl Alkyl Isocyanate Molecule and Surface Modified Mineral Substrate | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2009-01-22 | — | — | US | disclosed |
| EP-1817425-A1 | TRICHLORO SILYL ALKYL ISOCYANATE MOLECULE AND SURFACE MODIFIED MINERAL SUBSTRATE | Centre National de la Recherche Scientifique (FR) | 2007-08-15 | — | — | EP | disclosed |
| WO-2006056490-A1 | TRICHLORO SILYL ALKYL ISOCYANATE MOLECULE AND SURFACE MODIFIED MINERAL SUBSTRATE | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2006-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023590-A1 | Trichloro Silyl Alkyl Isocyanate Molecule and Surface Modified Mineral Substrate | TST, MSMO1, ESPL1 | MAPT 3508/4885ACE2 3868/4885GPR84 4273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.